Masimo Corporation (MASI)
| Previous close | 137.00 |
| Open | 138.64 |
| Bid | 136.49 x 100 |
| Ask | 137.14 x 100 |
| Day's range | 135.86 - 139.50 |
| 52-week range | 75.22 - 188.14 |
| Volume | |
| Avg. volume | 500,150 |
| Market cap | 7.228B |
| Beta (5Y monthly) | 0.98 |
| PE ratio (TTM) | 90.70 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | 23 Nov 2012 |
| 1y target est | N/A |
- Business Wire
Masimo Receives FDA Clearance for Stork™ Over-the-Counter (OTC) Baby Monitoring System
IRVINE, Calif., May 06, 2024--The Masimo Stork™ baby monitoring system has received FDA clearance for use over the counter (OTC) without the need for a prescription.
- Business Wire
Masimo to Report First Quarter 2024 Financial Results after Market Close on Tuesday, May 7
IRVINE, Calif., April 23, 2024--Masimo (NASDAQ: MASI) will release first quarter 2024 financial results for the period ended March 30, 2024, after the market closes on Tuesday, May 7, 2024. The conference call to review the results will begin at 1:30 p.m. PT (4:30 p.m. ET) and will be hosted by Joe Kiani, Chairman and Chief Executive Officer, and Micah Young, Executive Vice President and Chief Financial Officer.
- Business Wire
Masimo Founder and CEO Joe Kiani to Speak on AI at Global Patient Safety Summit in Chile
SANTIAGO, Chile, April 16, 2024--Masimo CEO Joe Kiani will speak at the Global Ministerial Summit on Patient Safety in Chile about how AI-based solutions can improve patient safety.
